We are pleased to announce that our Laboratory Testing Division (LTD) has launched preclinical medical device testing services in China.  These services are  being offered for Chinese and international clients for their product registration with the China Food and Drug Administration (CFDA) and for Chinese clients for product registration in global markets.  LTD’s preclinical medical device testing services in China include a complete portfolio of biocompatibility, microbiology, and chemistry testing services.   Our operations in Shanghai and Suzhou have successfully passed inspections by the FDA, CFDA, and OECD and audits by many clients for GLP studies.  WuXi has been a leader in providing preclinical and clinical medical device testing services in the United States for many years.  With China’s rapidly growing medical device industry, we are committed to providing domestic and international medical device companies with the same high quality of testing services in China that we have provided for years in the United States.

 

Related Links:

WuXi to Be Exclusive Supplier of Laboratory Testing Services to Lee’s Pharm
WuXi Expands in U.S. With Acquisition of XenoBiotic Laboratories, Inc.